Search

everythinglearnresearchcommunity

for

Search:↓

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

A Gsdma3 mutation causes hair loss due to stem cell damage from skin inflammation.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

GRK2 is essential for healthy hair follicle function, and its absence can lead to hair loss and cysts.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Different stem cells are key for hair growth and health, and understanding their regulation could help treat hair loss.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Systemic mastocytosis may cause a type of hair loss called cicatricial alopecia.

Different hair diseases affect people during childbearing years, with treatments ranging from medication to psychological support.

Trichoscopy helps diagnose and assess the severity of Frontal Fibrosing Alopecia.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

A 70-year-old woman with a rare skin condition improved after treatment with topical steroids and acitretin.

Altered retinoid metabolism in cicatricial alopecia suggests a balanced vitamin A diet may prevent the condition.